Treatment of stage I and II osteonecrosis of the femoral head with core decompression and bone marrow aspirate concentrate injection-A 2-year follow-up study

The goals of treatment for ONFH are to preserve function, reduce pain, and delay the need for THA. Our study has demonstrates that CD-BMAC may be a worthwhile treatment modality in patients with stage I or II ONFH. However, future randomized control trials comparatively evaluating the effectiveness of CD-BMAC to a control are necessary to better understand the clinical impact associated with BMAC therapy.